We build breakthrough biotechs

Biotech

Creating and building breakthrough biotechs for over 30 years

People

Partnering with the world's best life science entrepreneurs

Impact

Translating groundbreaking science into life-changing medicines
Scroll to explore
2
Latest news
Atlas Venture 2023 Year In Review
Find out more
Q32 Bio to take Homology Medicines’ Nasdaq spot to fund PhII trials in autoimmune, inflammatory conditions
Find out more

Thirty years at the leading-edge of medical innovation and we’re just getting started.

Discover Portfolio Team
~ Measuring our impact

>25

Medicines made by Atlas portfolio companies

~ Measuring our impact

70

Startups launched from the Atlas incubator

~ Measuring our impact

39

IPOs

~ Measuring our impact

32

M&A Exits

01